Press Releases April 16, 2026 08:00 PM

BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB896 Million in 2026

KANZHUN LIMITED reinforces shareholder value with substantial share repurchase program in 2026

By Derek Hwang BZ
BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB896 Million in 2026
BZ

KANZHUN LIMITED, trading as BOSS Zhipin, announced continued share repurchases in 2026 totaling over RMB896 million, demonstrating its strong commitment to enhancing shareholder returns through its ongoing buyback program.

Key Points

  • KANZHUN LIMITED repurchased 344,394 ordinary shares on April 16, 2026, for RMB17.1 million.
  • Year-to-date share repurchases exceed RMB896 million, reflecting a significant investment in the company's own stock.
  • The share repurchase program signals management's confidence in the company's future and dedication to increasing shareholder value.

BEIJING, April 17, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing nearly RMB17.1 million to repurchase 344,394 ordinary shares on April 16. Year-to-date in 2026, the Company has deployed over RMB896 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns.


Risks

  • Share repurchases use substantial cash resources, which could otherwise be invested in growth opportunities, impacting future expansion.
  • Market conditions or regulatory changes could affect the continuation or effectiveness of the share repurchase program.
  • If the stock price does not respond positively, the buybacks might not translate into expected shareholder value enhancement.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026